Literature DB >> 201170

Viral hepatitis: enzyme assays and serologic procedures in the study of an epidemic.

J Rakela, E Nugent, J W Mosley.   

Abstract

An epidemic of viral hepatitis beginning in late 1975 in a residence for multiply handicapped children, recognized very early in its course, was investigated prospectively to permit comparison of enzymatic and serologic tests. Thirty-three residents of the institution and 46 full- and part-time employees were studied by the immune adherence hemagglutination procedure for antibody (anti-HAV) to hepatitis A virus (HAV). Of these, 31 residents and 37 staff members were susceptible at the beginning of the epidemic. Nineteen and six, respectively, had anti-HAV seroconversion indicating HAV infection. Thus, 12 children (39%) and 31 staff members (81%) of presumed susceptibles did not have serologic evidence of infection. The subclinical/clinical ratio for the children was 1.1:1; for personnel, it was 1:1. Serum alanine aminotransferase (ALT) levels compatible with viral hepatitis occurred in 21 persons (84%) who had anti-HAV seroconversion; conversely, there were 10 persons who had ALT abnormality without detectable anti-HAV in late specimens among the total of 68 susceptibles. There was no evidence the latter could be attributed to hepatitis B virus infection; therefore, they may represent the endemic occurrence of non-A, non-B agent(s).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201170     DOI: 10.1093/oxfordjournals.aje.a112497

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

Review 1.  Non-A, non-B hepatitis.

Authors:  T N Dewar
Journal:  West J Med       Date:  1990-08

2.  Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel.

Authors:  M S Green; C Block
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

3.  Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.

Authors:  J D Kark; S Bar-Shany; S Shor; L Merlinski; E Nili
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

4.  Immunoprophylaxis of hepatitis A of the children by immune serum globulin.

Authors:  R Kinoshita; S Hirose; K Miura; T Nakagawa; Y Imai; S Suzuki
Journal:  Gastroenterol Jpn       Date:  1984-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.